sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. filed Form 8.3 with the Irish Takeover Panel regarding its position in Mural Oncology plc. As of August 22, 2025, Vanguard controls 771,571 ordinary shares, which represents a 4.47% interest in Mural Oncology. This disclosure follows the rules set by the Irish Takeover Panel Act of 1997.
No short positions are held by Vanguard in the relevant securities, and no cash-settled or stock-settled derivatives are reported. Recent transactions include the purchase of 32 and the sale of 128 ordinary shares at a price of 2.08 USD per unit.
There are no indemnity agreements, options, or other arrangements in place that would affect Vanguard's dealings with Mural Oncology securities. Vanguard has not engaged in any agreements affecting voting rights or future acquisition or disposal of securities.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.